Thursday, February 23, 2012 7:41:46 AM
(Recasts, add details, quotes from prime minister, central bank chief)
By Ari Rabinovitch and Steven Scheer
JERUSALEM, Feb 22 (Reuters) - Israel's government, under pressure to lower the cost of living, said on Wednesday it would break up some of the country's largest conglomerates as part of a plan to reduce concentration and boost competition in the economy.
Israel has one of the highest concentrations of corporate power in the developed world and the Finance Ministry said the country's 10 largest business groups controlled 41 percent of the market value of public companies.
"There is no phenomenon of concentration in the OECD like in the Israeli economy," Prime Minister Benjamin Netanyahu told a news conference where a government panel presented its final recommendations.
"I am a proponent of competition and against monopolies and cartels," said Netanyahu, who as finance minister a decade ago implemented free market and economic structural reforms.
The main recommendations, which need cabinet and parliamentary approval, include requiring conglomerates with significant financial and non-financial assets to divest.
Holding companies structured like pyramids will have to limit their tiers of subsidiaries in a move designed to change the current set-up, in which parent companies often own publicly listed units which in turn have their own listed subsidiaries.
Under the new rules, existing groups will be allowed no more than three tiers of subsidiaries and new conglomerates two.
Institutional investors must also curb credit issuance.
Companies will have four years to comply with the new rules. The panel published interim recommendations last September.
Israel's conglomerates have been partly blamed for driving up prices of basic goods, leading to mass protests last summer which are expected to resume in coming weeks. The government is also under pressure to stem the tide of debt settlements due to their impact on pensions.
"Today we are talking about concentration, but a very important factor related to increased competitiveness is imports," Bank of Israel Governor Stanley Fischer said. "We must continue to liberalise imports -- that is the best way to increase competitiveness in the economy."
WHAT TO KEEP, WHAT TO SELL
According to the recommendations, companies cannot hold a bank or other financial firm with assets above 40 billion shekels ($11 billion) as well as a non-financial company of more than 6 billion shekels or revenue.
As a result, the IDB Group would have to divest Clal Insurance or other key holdings such as Cellcom , Israel's largest mobile phone operator. And Delek Group would have to decide between keeping insurance company Phoenix and brokerage Excellence Nessuah or its massive fuel business -- which includes a number of offshore natural gas wells.
Also, private equity firm Apax Partners would need to choose between food maker Tnuva or the Psagot brokerage.
<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ For a Special Report on Israel's economic concentration
click on:
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>
"This report is not intended as an attack on the business sector. Everyone realises that the economy cannot be managed on the basis of government production alone," said Fischer.
"We have to rely on the business sector, but must ensure that it operates efficiently and without influencing the political system."
Earlier this month, IDB said it planned to merge two of its intermediate holding companies to simplify its pyramid-type structure and reduce costs. Discount Investment Corp would buy the portion of Koor Industries it does not already own.
($1 = 3.77 shekels)
(Additional reporting by Tova Cohen; Editing by Helen Massy-Beresford)
((steven.scheer@thomsonreuters.com)(+972 2 632 2210)(Reuters Messaging: steven.scheer.thomsonreuters.com@reuters.net))
Keywords: ISRAEL ECONOMY/COMPETITION
Recent CEL News
- Celadon Pharmaceuticals PLC Result of AGM • RNS Regulatory News • 06/28/2024 06:00:12 AM
- Celadon Pharmaceuticals PLC Second Admission of Shares • RNS Regulatory News • 06/07/2024 06:00:09 AM
- No Headline Available • Alliance News • 06/03/2024 05:01:12 PM
- Celadon Pharmaceuticals PLC Publication of Annual Report & Notice of AGM • RNS Regulatory News • 06/03/2024 04:45:01 PM
- Celadon ships to US; Oxford BioDynamics-Goodbody pact • Alliance News • 05/23/2024 08:08:53 PM
- Celadon Pharmaceuticals PLC Supply of Products to New US Customer • RNS Regulatory News • 05/23/2024 06:00:13 AM
- Celadon Pharmaceuticals PLC Exercise of Share Options and Total Voting Rights • RNS Regulatory News • 05/15/2024 01:45:01 PM
- Headlam warns of loss; EnSilica predicts revenue rise • Alliance News • 05/14/2024 06:41:32 PM
- Celadon Pharmaceuticals PLC Final Results • RNS Regulatory News • 05/14/2024 06:00:12 AM
- Celadon raises GBP2 million, extends credit facility • Alliance News • 05/10/2024 05:57:23 PM
- Celadon Pharmaceuticals PLC Fundraise, RCF Extension, Termination of CLN & TVR • RNS Regulatory News • 05/10/2024 06:00:08 AM
- Celadon hails early results of chronic pain trial • Alliance News • 03/08/2024 08:04:45 PM
- Celadon Pharmaceuticals PLC Early Economic Analysis of Feasibility Study Data • RNS Non-Regulatory • 03/07/2024 07:00:13 AM
- Celadon announces start of cannabis supply for two UK companies • Alliance News • 12/14/2023 02:18:53 PM
- Celadon Pharmaceuticals PLC Product Supplied to First Two Sales Contracts • UK Regulatory • 12/14/2023 07:00:00 AM
- Celadon Pharma raises GBP2.0 million via placing • Alliance News • 12/12/2023 05:40:04 PM
- Celadon Pharmaceuticals PLC Fundraise, Update on Future CLN Financing & TVR • UK Regulatory • 12/12/2023 02:00:00 PM
- Celadon shares rise on supply contract worth up to GBP26 million • Alliance News • 11/16/2023 11:45:35 AM
- Celadon Pharmaceuticals PLC New European Sales Contract • UK Regulatory • 11/16/2023 07:00:00 AM
- Celadon Pharmaceuticals raises GBP1.0 million through shares • Alliance News • 10/13/2023 02:42:26 PM
- Celadon Pharmaceuticals PLC Fundraise, CLN Issue, Joint Broker Appointed & TVR • UK Regulatory • 10/13/2023 06:00:00 AM
- Celadon Pharmaceuticals interim loss narrows; optimistic for future • Alliance News • 09/28/2023 11:14:47 AM
- Celadon Pharmaceuticals PLC Interim Results • UK Regulatory • 09/28/2023 06:00:00 AM
- Celadon Pharmaceuticals PLC Notice of Results and Investor Presentation • UK Regulatory • 09/18/2023 06:00:00 AM
- Celadon shares rise on second UK contract win for cannabis product • Alliance News • 09/05/2023 09:48:42 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM